Detalles de la búsqueda
1.
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens.
BMC Infect Dis
; 23(1): 227, 2023 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37059996
2.
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade.
HIV Med
; 23(1): 70-79, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34473897
3.
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
BMC Infect Dis
; 22(1): 745, 2022 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151508
4.
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients.
J Antimicrob Chemother
; 75(9): 2547-2553, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32464638
5.
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study.
BMC Public Health
; 20(1): 734, 2020 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32434482
6.
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.
J Antimicrob Chemother
; 74(11): 3295-3304, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504633
7.
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study.
BMC Infect Dis
; 19(1): 555, 2019 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31238916
8.
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients.
New Microbiol
; 42(3): 150-155, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31305935
9.
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA).
BMC Infect Dis
; 18(1): 357, 2018 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-30064371
10.
HPV infection and pre-neoplastic cervical lesions among 321 HIV+ women in Florence, Italy, 2006-2016: prevalence and associated factors.
New Microbiol
; 41(4): 268-273, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30252922
11.
Comments on "Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C".
J Med Virol
; 94(2): 436-438, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34499359
12.
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects.
Pharmacol Res
; 176: 106064, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34999223
13.
Variants in the CYP7B1 gene region do not affect natural resistance to HIV-1 infection.
Retrovirology
; 12: 80, 2015 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26399852
14.
Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort.
Front Med (Lausanne)
; 10: 1086012, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36778739
15.
Incident diabetes in course of antiretroviral therapy.
AIDS
; 37(8): 1269-1276, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927963
16.
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting.
Viruses
; 15(7)2023 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515298
17.
The measurement of the sink properties of triethanolamine (TEA) as a coating for collecting NO2 by using annular diffusion denuders.
Environ Technol
; 33(7-9): 1065-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22720435
18.
Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in Italy.
J Clin Med
; 11(2)2022 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35054165
19.
Reversibility of Central Nervous System Adverse Events in Course of Art.
Viruses
; 14(5)2022 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35632768
20.
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study.
Viruses
; 14(11)2022 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366413